Impact of stage migration and practice changes on high-risk prostate cancer: results from patients treated with radical prostatectomy over the last two decades

被引:28
|
作者
Fossati, Nicola [1 ,2 ]
Passoni, Niccolo M. [1 ,3 ]
Moschini, Marco [1 ]
Gandaglia, Giorgio [1 ]
Larcher, Alessandro [1 ]
Freschi, Massimo [4 ]
Guazzoni, Giorgio [5 ]
Sjoberg, Daniel D. [2 ]
Vickers, Andrew J. [2 ]
Montorsi, Francesco [1 ]
Briganti, Alberto [1 ]
机构
[1] IRCCS, Osped San Raffaele, URI, Div Oncol,Unit Urol, Milan, Italy
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
[4] IRCCS, Osped San Raffaele, Dept Pathol, Milan, Italy
[5] Humanitas Univ, Humanitas Clin & Res Ctr, Dept Urol, Milan, Italy
关键词
prostate cancer; high risk; radical prostatectomy; stage migration; cancer recurrence; ADJUVANT RADIOTHERAPY; CANDIDATE; OUTCOMES; THERAPY; TRIAL; MEN;
D O I
10.1111/bju.13125
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To evaluate the impact of year of surgery on clinical, pathological and oncological outcomes of patients with high-risk prostate cancer. Patients and Methods We evaluated 1 033 patients with clinically high-risk prostate cancer, defined as the presence of at least one of the following risk factors: preoperative prostate-specific antigen (PSA) level >20 ng/mL, and/or clinical stage >= T3, and/or biopsy Gleason score >= 8. Patients were treated between 1990 and 2013 at a single institution. The year-by-year trends in clinical and pathological characteristics were examined. Multivariable Cox regression analysis was used to test the relationship between year of surgery and oncological outcomes. Results We observed a decrease over time in the proportion of patients with high-risk disease (preoperative PSA >20 ng/mL or clinical stage cT3). A trend in the opposite direction was seen for biopsy Gleason score >= 8 tumours. We observed a considerable increase in the median number of lymph nodes removed, which was associated with an increased rate of lymph node invasion (LNI). On multivariable Cox regression analysis, year of surgery was associated with a reduced risk of biochemical recurrence (hazard ratio [HR] per 5-year interval 0.90, 95% confidence interval [CI] 0.84-0.96; P = 0.01) and distant metastasis (HR per 5-year interval 0.91, 95% CI 0.83-0.99; P = 0.039), after adjusting for age, preoperative PSA, pathological stage, LNI, surgical margin status, and pathological Gleason score. Conclusions In this single-centre study, an increased diagnosis of localized and less extensive high-grade prostate cancer was observed over the last two decades. Patients with high-risk disease who were selected for radical prostatectomy showed better cancer control over time. Better definitions of what constitutes high-risk prostate cancer among contemporary patients are needed.
引用
收藏
页码:740 / 747
页数:8
相关论文
共 50 条
  • [1] Migration in last decade to high-risk prostate cancer after radical prostatectomy
    Patard, P. -M.
    Roumiguie, M.
    Prudhomme, T.
    Doumerc, N.
    Thoulouzan, M.
    Game, X.
    de la Taille, A.
    Rischmann, P.
    Soulie, M.
    Salomon, L.
    Beauval, J. -B.
    PROGRES EN UROLOGIE, 2019, 29 (01): : 29 - 35
  • [2] Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancer
    Dell'Oglio, Paolo
    Karnes, Robert Jeffrey
    Joniau, Steven
    Spahn, Martin
    Gontero, Paolo
    Tosco, Lorenzo
    Fossati, Nicola
    Kneitz, Burkhard
    Chlosta, Piotr
    Graefen, Markus
    Marchioro, Giansilvio
    Bianchi, Marco
    Sanchez-Salas, Rafael
    Karakiewicz, Pierre I.
    Van Poppel, Hendrik
    Montorsi, Francesco
    Briganti, Alberto
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (05) : 234.e13 - 234.e19
  • [3] Identifying the Best Candidate for Radical Prostatectomy Among Patients with High-Risk Prostate Cancer
    Briganti, Alberto
    Joniau, Steven
    Gontero, Paolo
    Abdollah, Firas
    Passoni, Niccolo M.
    Tombal, Bertrand
    Marchioro, Giansilvio
    Kneitz, Burkhard
    Walz, Jochen
    Frohneberg, Detlef
    Bangma, Chris H.
    Graefen, Markus
    Tizzani, Alessandro
    Frea, Bruno
    Karnes, R. Jeffrey
    Montorsi, Francesco
    Van Poppel, Hein
    Spahn, Martin
    EUROPEAN UROLOGY, 2012, 61 (03) : 584 - 592
  • [4] Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?
    Nagao, Kazuhiro
    Matsuyama, Hideyasu
    Matsumoto, Hiroaki
    Nasu, Takahito
    Yamamoto, Mitsutaka
    Kamiryo, Yoriaki
    Baba, Yoshikazu
    Suga, Akinobu
    Tei, Yasuhide
    Yoshihiro, Satoru
    Aoki, Akihiko
    Shimabukuro, Tomoyuki
    Joko, Keiji
    Sakano, Shigeru
    Takai, Kimio
    Yamaguchi, Shiro
    Akao, Jumpei
    Kitahara, Seiji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (04) : 757 - 764
  • [5] Are high-risk prostate cancer patients being treated equally? The impact of PSA
    Kord, Eyal
    Ferenczi, Basil
    DiNatale, Renzo G.
    Daily, Adam
    Koenig, Hannah
    Frankel, Jason
    Jung, Nathan
    Flores, John Paul
    Porter, Christopher
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (04) : 204.e17 - 204.e25
  • [6] Laparoscopic Radical Prostatectomy in Patients with High-Risk Prostate Cancer: Feasibility and Safety. Results of a Multicentric Study
    Varca, Virginia
    Benelli, Andrea
    Perri, Davide
    Gozen, Ali Sedar
    Fiedler, Marcel
    de la Taille, Alexandre
    Casazza, Giovanni
    Salomon, Laurent
    Rassweiler, Jens
    Gregori, Andrea
    Gaboardi, Franco
    JOURNAL OF ENDOUROLOGY, 2018, 32 (09) : 843 - 851
  • [7] Impact of "Time-From-Biopsy-to-Prostatectomy" on Adverse Oncological Results in Patients With Intermediate and High-Risk Prostate Cancer
    Engl, Tobias
    Mandel, Philipp
    Hoeh, Benedikt
    Preisser, Felix
    Wenzel, Mike
    Humke, Clara
    Welte, Maria
    Koellermann, Jens
    Wild, Peter
    Deuker, Marina
    Kluth, Luis A.
    Roos, Frederik C.
    Chun, Felix K. H.
    Becker, Andreas
    FRONTIERS IN SURGERY, 2020, 7
  • [8] Long-term oncological results of treatment for high-risk prostate cancer using radical prostatectomy in a cancer hospital
    Rubio-Briones, J.
    Ramirez-Backhaus, M.
    Gomez-Ferrer, A.
    Mir, C.
    Dominguez-Escrig, J.
    Collado, A.
    Iborra, I.
    Casanova, J.
    Solsona, E.
    Mascaros, J. M.
    Calatrava, A.
    ACTAS UROLOGICAS ESPANOLAS, 2018, 42 (08): : 507 - 515
  • [9] Oncological and functional results after robot-assisted radical prostatectomy in high-risk prostate cancer patients
    Sanchez-Nunez, Juan E.
    Gonzalez-Cuenca, Eduardo
    Fernandez-Noyola, Gerardo
    Gonzalez-Bonilla, Eduardo A.
    Doria-Lozano, Mario
    Rosas-Nava, Jesus E.
    Corona-Montes, Victor E.
    CIRUGIA Y CIRUJANOS, 2022, 90 : 1 - 7
  • [10] Tailored treatment including radical prostatectomy and radiation therapy plus androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: results from a prospective study
    Castelli, Tommaso
    Russo, Giorgio Ivan
    Favilla, Vincenzo
    Urzi, Daniele
    Spitaleri, Fabio
    Reale, Giulio
    Giardina, Raimondo
    Saita, Alberto
    Madonia, Massimo
    Cimino, Sebastiano
    Morgia, Giuseppe
    INTERNATIONAL BRAZ J UROL, 2014, 40 (03): : 322 - 329